• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对肝细胞癌中 NCOA3-SP1-TERT 轴的肿瘤生长。

Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma.

机构信息

Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.

Institute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.

出版信息

Cell Death Dis. 2020 Nov 25;11(11):1011. doi: 10.1038/s41419-020-03218-x.

DOI:10.1038/s41419-020-03218-x
PMID:33239622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7689448/
Abstract

Hepatocellular carcinoma (HCC) has a high mortality rate and lacks an effective therapeutic target. Elevated expression of human telomerase reverse transcriptase (TERT) is an important hallmark in cancers, but the mechanism by which TERT is activated differentially in cancers is poorly understood. Here, we have identified nuclear receptor coactivator-3 (NCOA3) as a new modulator of TERT expression and tumor growth in HCC. NACO3 specifically binds to the TERT promoter at the -234 to -144 region and transcriptionally activates TERT expression. NCOA3 promotes HCC cell growth and tumor progression in vitro and in vivo through upregulating the TERT signaling. Knockdown of NACO3 suppresses HCC cell viability and colony formation, whereas TERT overexpression rescues this suppression. NCOA3 interacts with and recruits SP1 binding on the TERT promoter. Knockdown of NCOA3 also inhibits the expression of the Wnt signaling-related genes but has no effect on the Notch signaling-targeting genes. Moreover, NCOA3 is positively correlated with TERT expression in HCC tumor tissues, and high expression of both NCOA3 and TERT predicts a poor prognosis in HCC patients. Our findings indicate that targeting the NCOA3-SP1-TERT signaling axis may benefit HCC patients.

摘要

肝细胞癌(HCC)死亡率高,缺乏有效的治疗靶点。人端粒酶逆转录酶(hTERT)的高表达是癌症的一个重要标志,但 hTERT 在癌症中差异激活的机制尚不清楚。在这里,我们鉴定出核受体共激活因子 3(NCOA3)是 HCC 中 hTERT 表达和肿瘤生长的新调节剂。NCOA3 特异性结合 hTERT 启动子的-234 至-144 区域,并转录激活 hTERT 表达。NCOA3 通过上调 hTERT 信号促进 HCC 细胞在体外和体内的生长和肿瘤进展。敲低 NCOA3 抑制 HCC 细胞活力和集落形成,而 hTERT 过表达可挽救这种抑制作用。NCOA3 与 TERT 启动子上的 SP1 结合并募集 SP1。敲低 NCOA3 也抑制 Wnt 信号相关基因的表达,但对 Notch 信号靶向基因没有影响。此外,NCOA3 在 HCC 肿瘤组织中与 hTERT 表达呈正相关,NCOA3 和 hTERT 的高表达预示着 HCC 患者预后不良。我们的研究结果表明,靶向 NCOA3-SP1-hTERT 信号轴可能有益于 HCC 患者。

相似文献

1
Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma.针对肝细胞癌中 NCOA3-SP1-TERT 轴的肿瘤生长。
Cell Death Dis. 2020 Nov 25;11(11):1011. doi: 10.1038/s41419-020-03218-x.
2
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma Progression.双特异性酪氨酸磷酸化调节激酶 3 的缺失激活嘌呤代谢并促进肝癌进展。
Hepatology. 2019 Nov;70(5):1785-1803. doi: 10.1002/hep.30703. Epub 2019 Jun 21.
3
BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.BPTF 通过调节端粒酶逆转录酶信号和癌症干细胞特征促进肝癌生长。
Redox Biol. 2019 Jan;20:427-441. doi: 10.1016/j.redox.2018.10.018. Epub 2018 Oct 25.
4
A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator.肝癌治疗的一个潜在靶点,溶血磷脂酸受体 6(LPAR6),其转录受到 NCOA3 共激活因子的上调。
J Biol Chem. 2020 Feb 7;295(6):1474-1488. doi: 10.1074/jbc.RA119.009899. Epub 2019 Dec 30.
5
Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.鉴定参与调控肝细胞癌 TERT 的基因。
Cancer Sci. 2019 Feb;110(2):550-560. doi: 10.1111/cas.13884. Epub 2019 Jan 4.
6
Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.类固醇受体辅激活因子1通过增强Wnt/β-连环蛋白信号促进人肝癌进展。
J Biol Chem. 2015 Jul 24;290(30):18596-608. doi: 10.1074/jbc.M115.640490. Epub 2015 Jun 16.
7
Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.端粒酶逆转录酶调节肝细胞癌中 DNMT3B 的表达/异常 DNA 甲基化表型和 AKT 激活。
Cancer Lett. 2018 Oct 10;434:33-41. doi: 10.1016/j.canlet.2018.07.013. Epub 2018 Jul 11.
8
Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma.非透明细胞型和透明细胞型肝细胞癌中端粒酶的启动子突变及细胞分布
Oncotarget. 2017 Apr 18;8(16):26288-26297. doi: 10.18632/oncotarget.15458.
9
Prediction of the prognosis of advanced hepatocellular carcinoma by TERT promoter mutations in circulating tumor DNA.循环肿瘤 DNA 中 TERT 启动子突变预测晚期肝细胞癌的预后。
J Gastroenterol Hepatol. 2021 Apr;36(4):1118-1125. doi: 10.1111/jgh.15227. Epub 2020 Sep 7.
10
RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.RBFOX3通过hTERT信号通路促进肿瘤生长和进展,并预测肝细胞癌预后不良。
Theranostics. 2017 Jul 22;7(12):3138-3154. doi: 10.7150/thno.19506. eCollection 2017.

引用本文的文献

1
Predicting cisplatin response in cholangiocarcinoma patients using chromosome pattern and related gene expression.利用染色体模式和相关基因表达预测胆管癌患者对顺铂的反应。
Sci Rep. 2025 Jul 1;15(1):20420. doi: 10.1038/s41598-025-06851-8.
2
The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics.肝细胞癌的表观遗传基础——生物标志物与治疗方法的机制及潜在方向
Br J Cancer. 2025 Jun;132(10):869-887. doi: 10.1038/s41416-025-02969-8. Epub 2025 Mar 8.
3
TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis.

本文引用的文献

1
Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma.失调的 Sp1/miR-130b-3p/HOXA5 轴促进肝癌的肿瘤血管生成和进展。
Theranostics. 2020 Apr 6;10(12):5209-5224. doi: 10.7150/thno.43640. eCollection 2020.
2
NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer.NPM1 上调 PD-L1 的转录并抑制三阴性乳腺癌中的 T 细胞活性。
Nat Commun. 2020 Apr 3;11(1):1669. doi: 10.1038/s41467-020-15364-z.
3
Sp1-regulated transcription of RasGRP1 promotes hepatocellular carcinoma (HCC) proliferation.
端粒酶逆转录酶-TP53突变:一种用于肝细胞癌复发和预后的新型生物标志物组合
Sci Rep. 2025 Jan 29;15(1):3620. doi: 10.1038/s41598-025-87545-z.
4
NCOA3 knockdown delays human embryo development.NCOA3基因敲低会延迟人类胚胎发育。
Heliyon. 2024 Sep 13;10(18):e37639. doi: 10.1016/j.heliyon.2024.e37639. eCollection 2024 Sep 30.
5
Extended replicative lifespan of primary resting T cells by CRISPR/dCas9-based epigenetic modifiers and transcriptional activators.基于 CRISPR/dCas9 的表观遗传修饰物和转录激活物延长原初静息 T 细胞的复制寿命。
Cell Mol Life Sci. 2024 Sep 17;81(1):407. doi: 10.1007/s00018-024-05415-9.
6
Pathological discrimination between luteinized thecoma associated with sclerosing peritonitis and thecoma.黄素化支持细胞瘤伴硬化性腹膜炎与支持细胞瘤的病理性鉴别。
Medicine (Baltimore). 2023 Jun 9;102(23):e33911. doi: 10.1097/MD.0000000000033911.
7
Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology.肝脏生理和病理中的特异性蛋白 (SP) 和 Krüppel 样因子 (KLF)。
Int J Mol Sci. 2023 Feb 28;24(5):4682. doi: 10.3390/ijms24054682.
8
Mapping Multi-factor-mediated Chromatin Interactions to Assess Dysregulation of Lung Cancer-related Genes.绘制多因素介导的染色质相互作用图,以评估肺癌相关基因的失调。
Genomics Proteomics Bioinformatics. 2023 Jun;21(3):573-588. doi: 10.1016/j.gpb.2023.01.004. Epub 2023 Jan 23.
9
Protective role of circRNA CCND1 in ulcerative colitis via miR-142-5p/NCOA3 axis.环状 RNA CCND1 通过 miR-142-5p/NCOA3 轴在溃疡性结肠炎中的保护作用。
BMC Gastroenterol. 2023 Jan 19;23(1):18. doi: 10.1186/s12876-023-02641-6.
10
Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma.肝细胞癌的发病机制与当前治疗策略
Biomedicines. 2022 Dec 9;10(12):3202. doi: 10.3390/biomedicines10123202.
Sp1 调控 RasGRP1 的转录促进肝细胞癌(HCC)增殖。
Liver Int. 2018 Nov;38(11):2006-2017. doi: 10.1111/liv.13757. Epub 2018 May 21.
4
ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.ZBP-89 和 Sp1 促进肝癌细胞中 Bak 的表达。
BMC Cancer. 2018 Apr 13;18(1):419. doi: 10.1186/s12885-018-4349-y.
5
TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter.TIP60通过抑制Sp1与端粒酶逆转录酶(TERT)启动子的结合来抑制端粒酶表达。
PLoS Pathog. 2017 Oct 18;13(10):e1006681. doi: 10.1371/journal.ppat.1006681. eCollection 2017 Oct.
6
Correlation between the expression of hTERT gene and the clinicopathological characteristics of hepatocellular carcinoma.hTERT基因表达与肝细胞癌临床病理特征的相关性
Oncol Lett. 2016 Jan;11(1):111-115. doi: 10.3892/ol.2015.3892. Epub 2015 Nov 9.
7
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications.线粒体信号传导与肝细胞癌:分子机制及治疗意义
Curr Pharm Des. 2016;22(18):2689-96. doi: 10.2174/1381612822666160209153624.
8
New molecular therapies for hepatocellular carcinoma.肝细胞癌的新型分子疗法
Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S80-5. doi: 10.1016/j.clinre.2015.06.016. Epub 2015 Jul 20.
9
Evaluation and management of hepatocellular carcinoma.肝细胞癌的评估与管理
Clin Liver Dis. 2015 Feb;19(1):23-43. doi: 10.1016/j.cld.2014.09.002. Epub 2014 Oct 30.
10
Hepatocellular carcinoma epidemiology.肝细胞癌流行病学
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):753-70. doi: 10.1016/j.bpg.2014.08.007. Epub 2014 Aug 23.